首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers.
【24h】

Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers.

机译:亚洲印第安人肝素诱导的血小板减少症患者中针对肝素-血小板因子4复合物的抗体的功能表征:与炎症标志物的相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

Occurrence of heparin-induced thrombocytopenia (HIT) was investigated for 33 Indian patients undergoing cardiovascular surgery who received unfractionated heparin (UFH). Platelet counts were performed prior to the initiation of UFH therapy and 5-16 days post therapy. Heparin-induced platelet aggregation, C-serotonin release assay, and enzyme-linked immmunosorbent assay (ELISA) tests were performed in all the patients to detect the antibodies formed against the complex of heparin and platelet factor 4 (HPF4). Levels of inflammatory markers/mediators such as CD40 ligand (CD40L) and C-reactive protein (CRP) were also measured in the patient plasmas utilizing ELISA tests. Based on clinical observations and laboratory diagnoses, five patients (15%) were considered to have confirmed HIT. Despite wide variations in the titers of inflammatory markers, patients who tested ELISA-positive for HPF4 antibodies showed markedly elevated levels of both soluble CD40L and C-reactive protein. Most strikingly, the C-serotonin release assay-positive patients showed up to a 10-fold increase in the level of CD40L. It is concluded that approximately 15% Asian-Indian patients receiving UFH during cardiovascular surgery develop functional HPF4 antibodies, which are associated with the increased levels of inflammatory markers/mediators in this catastrophic HIT syndrome.
机译:对33名接受普通肝素(UFH)接受心血管手术的印度患者进行了肝素诱导的血小板减少症(HIT)的调查。在开始UFH治疗之前和治疗后5-16天进行血小板计数。在所有患者中进行肝素诱导的血小板聚集,C-5-羟色胺释放测定和酶联免疫吸附测定(ELISA)测试,以检测针对肝素和血小板因子4(HPF4)的复合物形成的抗体。还使用ELISA测试在患者血浆中测量了炎症标记物/介体的水平,例如CD40配体(CD40L)和C反应蛋白(CRP)。根据临床观察和实验室诊断,认为5例(15%)确诊为HIT。尽管炎症标志物的滴度差异很大,但检测ELISA阳性的HPF4抗体的患者显示可溶性CD40L和C反应蛋白的水平均显着升高。最引人注目的是,C血清素释放测定阳性的患者显示CD40L水平最多增加10倍。结论是,在心血管外科手术期间接受UFH的大约15%的亚裔印度患者会产生功能性HPF4抗体,该抗体与这种严重HIT综合征中炎症标志物/介质的水平升高有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号